Thymalin Is a Fraction, Not a Molecule

Thymalin is not a molecule. It is a preparation, and almost every question that can be asked about a defined peptide has no answer for it. Understanding why is more useful than any specification a document could carry.

A fraction rather than a sequence

Thymalin is described in the literature as a polypeptide fraction obtained from thymic tissue. A fraction is what remains after a separation step has removed some components and retained others: it is defined by the procedure that produced it, not by a formula.

That means there is no single sequence, no single molecular formula and no single molecular mass. There is a population of polypeptides whose composition depends on the source material and on the extraction and purification steps applied to it.

What a certificate can and cannot state

For a defined peptide, a certificate reports a sequence, a calculated mass, a measured mass and a purity figure, and each of those has an unambiguous meaning. For a fraction, three of those four do not exist.

• Mass. A mass spectrum of a fraction shows a distribution, not a peak. It can be characterised, but it cannot be compared against a calculated value because there is none.
• Purity. Area percentage measures the proportion of one chromatographic peak against the total. For a fraction, the material is many peaks by design, so a high area percentage would indicate that the preparation is not what it claims to be.
• Sequence. Undefined.
• Identity. Established, where it is established at all, by showing that the preparation matches a reference profile, not by matching a number.

What a document for a fraction can legitimately state is the source material, the process, a total protein or total nitrogen content, a chromatographic or electrophoretic profile, and tests for contaminants. Those are real measurements. They are simply different measurements.

Batch-to-batch variation is structural, not a defect

Two lots of a synthetic peptide with the same sequence are the same compound, and any difference between them is impurity. Two lots of a tissue-derived fraction can differ in composition even when both were produced correctly, because the starting material differed.

This is why profile comparison rather than numerical specification is the appropriate control, and why the phrase batch-to-batch consistency means something different for a fraction than it does for a synthetic molecule.

Thymalin is not thymosin alpha-1

The two appear near each other in catalogues and are sometimes described as though one were a synonym or a purified version of the other. They are not the same thing.

Thymosin alpha-1 is a defined 28-residue acetylated peptide with a calculated mass near 3108 daltons and a CAS registry number of its own. It can be synthesised and characterised exactly like any other peptide. Thymalin is a fraction. A fraction may contain molecules that are also available in defined form, but the preparation is not the molecule.

Thymosin beta-4 is a third, separate compound: a 43-residue actin-binding peptide unrelated in sequence to thymosin alpha-1 despite the shared name. The word thymosin refers to origin rather than to a structural family.

Why the distinction matters for documentation

A certificate for a fraction that reports a single mass and a single purity percentage has borrowed a template from synthetic peptide work and filled it in with numbers that do not describe the material. This is not necessarily an attempt to mislead; it is often just the wrong form.

The informative version says what the material is, what process produced it, and what was measured. A reader who knows the difference can tell those two kinds of document apart at a glance, which is the practical reason to know it.

Other preparations in the same category

Several products listed alongside defined peptides are fractions or mixtures rather than single molecules. Cerebrolysin is described as a peptide preparation derived from porcine brain tissue. Various organ-derived extracts are described similarly.

The test is simple: if a compound has a single sequence and a single calculated mass, it is a defined molecule and it can carry a conventional certificate. If it does not, it is a preparation and it needs a different kind of documentation. Neither category is inferior; they are different kinds of thing and they are characterised differently.

What a document for a fraction should contain

A statement of the source and the process; a chromatographic or electrophoretic profile with a reference profile to compare against; a total content figure by a method appropriate to a mixture; and contaminant testing. A calculated molecular mass on such a document is a sign that the template, not the material, determined what was written.

The defined peptides that share the name

Thymosin alpha-1 is a defined 28-residue sequence and is characterised conventionally; it is covered in thymosin alpha-1 sequence, mass and detection. Thymosin beta-4 is a third, unrelated compound, discussed in thymosin beta-4 versus the TB-500 fragment.